22
2021 Company Introduction ANAPATH

ANAPATH 2021 Company Introduction

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: ANAPATH 2021 Company Introduction

2021Company Introduction

ANAPATH

Page 2: ANAPATH 2021 Company Introduction

AnaPath is a global contract research organization (CRO) and pathology services company that

provides preclinical and bioanalytical R&D solutions. AnaPath is the result of the merger

between two companies: AnaPath Services, based in Switzerland and specializing in pathology,

and AnaPath Research, based in Barcelona and focused on preclinical development.

AnaPath Services emerged from RCC/Harlan and was established in 2013. It is located close

to the pharmaceutical capital Basel and has quickly developed into a globally recognized

company owing to its expertise. AnaPath Services is well known for its scientific competence

in toxicologic pathology, fast turnaround times and reliability.

AnaPath Research was founded in 1980 as Cidasal. Over the years the company has been

part of various multinational corporations, such as RCC, Harlan and Envigo, providing high

quality services to our sponsors at all times. At the end of 2019, AnaPath Services acquired

the site to continue together the journey towards excellence in research.

As of November 2020, AnaPath operates a liaison office in Korea. The site is headed by CEO

Guk Jin Son, a respected partner of AnaPath for many years. Through AnaPath Korea, our

Asian clients are supported throughout the drug development process. AnaPath Korea

facilitates constant and clear communication between the client and the scientific experts

at AnaPath, thus ensuring the proper development of the projects.

AnaPath’s different departments work in perfect coordination to support the pharmaceutical,

chemical, agrochemical and veterinary industries. The facilities have GLP (Good Laboratory

Practice) certification and studies are performed in compliance with national and international

regulatory guidelines.

2

Page 3: ANAPATH 2021 Company Introduction

Index

General Toxicology 6

Analytical & Bioanalytical Services 8

Quality Assurance 10

Animal Welfare Body 10

Clinical Sciences & Sample Management 11

Veterinary Services 12

Animal House 13

Necropsy & Histology 16

Pathology 17

Molecular Pathology 18

Special Technologies 19

3

Page 4: ANAPATH 2021 Company Introduction

4

Proud of our track record, we provide solutions backed by years of experience.

Page 5: ANAPATH 2021 Company Introduction

General ToxicologyGeneral Toxicology - rodents and

non-rodents

• Single-dose administration

• Pharmacokinetics and toxicokinetics

• Maximum-tolerated-dose studies

• Repeat-dose administration (sub-acute, sub-chronic and chronic studies)

• Carcinogenicity studies

Safety Pharmacology Studies

• Effects on cardiovascular and respiratory system – telemetric measurements

• Central nervous system assessment (Modified Irwin test, FOB)

• Supplementary safety studies

• A variety of tailored animal model studies

Developmental and Reproductive Toxicology (DART)

• Reproduction/developmental toxicity screening

• Fertility and Early Embryonic Development

• Embryo-Fetal Development

• Pre- and Postnatal Development

• Multigenerational studies

• Extended One Generation

• Juvenile Toxicity

General Toxicology performs a full

range of studies to support the

pharmaceutical, chemical,

agrochemical and veterinary

industries.

Our team consists of senior scientists

with an average of 20 years of

experience in toxicology,

pharmacokinetics and safety

pharmacology, and wide knowledge

of the current regulatory guidelines.

We offer scientific advice on study

types, study design and choice of dose

levels before starting with first-in-

human trials.

As a GLP-certified and AAALAC-

accredited center, we fully embrace the

3Rs of animal welfare. We are strongly

convinced that our animal welfare

policies have a positive impact on our

studies.

5

Page 6: ANAPATH 2021 Company Introduction

6

Non-rodent StudiesOur in-house expertise of more than 30

years working with NHP and dog

species allows us to offer a full range of

standard general toxicology,

pharmacology and pharmacokinetics

studies, apart from more tailored

studies depending on the sponsor’s

needs.

With more than 15 years of

experience, implantable and jacket

telemetry provides quality results

and meets the regulatory

requirements for pre-clinical testing.

Our location in the bioregion of

Catalonia gives us the added

advantage of being able to

effortlessly liaise with partners in

the area to perform specific

procedures.

Over the years we have worked with

a full range of different kinds of

products, including monoclonal

therapy, biosimilar and vaccinal

products.

Non-human Primate Studies

Our highly trained staff is able to perform a full range ofdifferent techniques. Here are some highlights:

• 1-hour infusion administration (includingaudiovisual enrichment during theprocedure)

• Juvenile toxicology studies

• Liver biopsies

• Telemetry of blood pressure, ECG and respiratory data in freely moving primates

• Anesthetized NHP models for specific molecule requirements; blood flow, dP/dT, blood gas measurements and a variety of vascular cannulations and surgical pharmacology procedures

Our experienced technicians are fully trained in the assessment of Central Nervous System in NHP, as part of toxicology or standalone studies, performing Functional Observation Battery.

Dog Studies

Owing to our vast experience in dog studies, we offer a wide range of studies including, but not limited to, the following techniques:

• Blood extraction from jugular, cephalic or saphenous veins

• Urinary bladder cannulation for urine collection

• Unrestrained dogs (implantable and jacket telemetry) to evaluate safety pharmacology core battery of cardiovascular and respiratory systems

• Up to 6-hour infusion administration (unrestrained method)

Page 7: ANAPATH 2021 Company Introduction

Analytical & Bioanalytical ServicesBioanalysis

• Bioanalysis for NCE supported by LC-MS/MS

• Analysis of macromolecules using ligand binding assays (non-clinical and clinical)

• Biologics supported by immunoassay platforms and LC-MS/MS

AnaPath’s bioanalytical team will

support your project all the way from

drug discovery, through preclinical

development and up to the clinical

phase. Whether it is method

development or routine sample

analysis, we are dedicated to

providing accurate, reliable and

streamlined bioanalytical services for

the most challenging programs to

help you make confident research

decisions.

Immunogenicity testing

• Determination of anti-drug antibodies (ADA) using ligand binding assays

• Titration assays using ligand binding assays

• Neutralizing antibody (nAb) assays

Biomarker determination

• Assistance to evaluate scientifically and biologically relevant biomarkers

• Biomarker determination in preclinical and clinical phases of drug development

• Development and qualification of novel biomarkers

• Fit-for-purpose GLP validation of established qualified assays

7

Page 8: ANAPATH 2021 Company Introduction

Flow cytometry testing

• Immunophenotyping in blood and organs

• Receptor occupancy assays

• Cellular response assays

Molecular biology

• Non-clinical study program for GTMP to properly assess the benefits and risks of such products when used in humans

• Nucleic acid-based therapeutic assessments, including biodistribution/shedding studies and quantitation of transgene mRNA for gene and cell therapies

• Gene expression analysis in blood and organs

• Separated qPCR facilities to prevent cross-contamination

Dose formulation analysis

• To confirm the correct dosing in in vivo studies and to support toxicology, genotoxicity and reprotoxicology by HPLC-UV/Vis and LC-MS/MS

Equipment

Real Time PCR (qPCR) Mx3005P (Stratagene)

HPLC (Waters)-API 4000TM (Sciex)

UPLC (Waters)-API 4000TM (Sciex)

UPLC (Waters)-API 5000TM (Sciex)

UPLC (Waters)-Triple Quad 6500+TM (Sciex)

BD FACSCanto™ II (3 lasers – 6 color configurations) (BD)

ELISA Spectramax 190C Microplate reader - UV mode

(Molecular Devices)

ELISA M3 Microplate reader - UV, fluorescence,

luminescence mode (Molecular Devices)

HPLC-UV/VIS, diode-array (DAD), fluorescence detectors

(Waters)

GxP systems

Softmax Pro GxP v 5.4.1 (Molecular Devices)

FACS Diva v8 (BD)

Mx Pro ET v4.10 (Strategene)

Analyst v1.4.2, v1.6.2 and v1.6.3 (Sciex)

Empower v2.0 (Waters)

8

Page 9: ANAPATH 2021 Company Introduction

Quality AssuranceAnaPath is certified in Good Laboratory Practice and has three Compliance Programs:

• Pharmaceutical, veterinary and cosmetic products, and medical device

• Agrochemical products

• Chemicals and food additives for human use

Being one of the first CROs to receive

GLP certification in the bioregion of

Spain, our Quality Assurance Unit

works to maintain and improve the

quality system to guarantee that the

studies performed at AnaPath comply

with the highest quality standards.

Our team of auditors have more than

15 years of experience in the field.

Animal WelfareBody

The Animal Welfare Body is an

indispensable component in a

research center like ours that uses

animals.

Its aim is to ensure that all experimental

procedures performed at AnaPath

comply with the current legislation and

to evaluate all procedures involving

animals.

As an AAALAC-accredited institution

since 2016, AnaPath Research fully

embraces the 3Rs of animal welfare

(replacement, refinement and

reduction). We are convinced that our

animal welfare policies have a positive

impact on our studies.

Animal Welfare Body is made up of:

• Animal Welfare Advisor

• One researcher

• One experienced scientist acting as an

external delegate

• A representative from the Quality Assurance

Unit not involved in the procedures acting as

an in-house delegate

• Head of Animal House

9

Page 10: ANAPATH 2021 Company Introduction

Clinical Sciences & Sample Management

AnaPath offers a wide range of clinical

sciences research services, including

the development of novel analytical

methods supported by a strong

expertise in the field.

We employ robust technologies

including industry gold standard

methodologies. Our processes and

data are managed via LIMS providing

high standards of quality control.

We perform test plasma and serum

biochemistry panels: full hematology

evaluation, including cell

morphology assessment, and urine

chemistry.

Through effective and efficient

processes, our team delivers

excellent support on sample

management procedures for cells,

plasma, serum, urine, among

others.

Biochemistry

AnaPath offers a standard biochemistry panel for the

different species used in preclinical studies and a wide

panel of biomarkers to meet our customer's needs.

• Cobas 6000 analyzer series delivers high quality

results based on experience, innovation and

advanced technologies

• Cobas u411 urine analyzer measures a wide range of

parameters

• Semi-automated gel electrophoresis instrument,

HYDRASYS, provides a complete test panel with high

sensitivity and good resolution

Hematology

AnaPath offers a standard hematology and hemostasis

panel for the different species used in preclinical studies.

• Advia 120 & 2120 flow cytometry–based system uses

light scatter, differential white blood cell (WBC) lysis,

and myeloperoxidase and oxazine 750 staining to

provide a complete blood cell count, a WBC

differential, and a reticulocyte count. A cyanide-free

method is used to measure hemoglobin

colorimetrically. In addition to its capability for

analyzing peripheral blood specimens, the analyzer is

also equipped to analyze cerebrospinal fluid samples.

• STA Compact Max® is a fully automatic coagulation

analyzer. The instrument utilizes barcoding of test

reagents, calibrators and controls.

10

Page 11: ANAPATH 2021 Company Introduction

Veterinary Services

The Veterinary Services Department

consists of the Veterinary Unit and

the Animal Welfare Unit.

Our main objective is to care for the

animals and their welfare in the best

possible way, making the quality of

the experimental system optimal for

the great variety of studies that we

carry out.

We have extensive experience in all

the species we work with, so we also

offer a veterinary advisory service to

AnaPath's team of researchers, as

well as actively participate in the

ongoing training of our animal

technicians and in the refinement of

experimental techniques.

Veterinary Unit

Animal health control

• Responsible for veterinary inspections and animal

health, scheduling and coordinating routine

prophylactic procedures

• Applying humane endpoints and ensuring the

correct application of animal welfare policies

• Managing animal adoption program (re-homing)

Control of the Animal House environmental conditions

• Scheduling, managing and reviewing microbiological

controls, water quality, light levels and air changes in

the animal facilities, as well as supervising diets and

bedding analysis

Animal Welfare Unit

Animal welfare control

• Establishing and improving the Animal Care and

Welfare Program and inspections for all species

• Establishing humane endpoints and ensuring

compliance with animal welfare policies

• Performing statistics of animal use at AnaPath

Research and reporting all animal-welfare-related

issues to the Animal Welfare Body

Consulting and training

• Ensuring continuous training for the Animal House

staff as well as Study Directors in animal care and

welfare-related matters, in the recognition of limiting

clinical signs and humane endpoints

11

Page 12: ANAPATH 2021 Company Introduction

AnimalHouse

The Animal House is the core of

AnaPath scientific activity. Over the

years, the department has evolved

and adapted to changes in legislation

and animal welfare

recommendations to minimize

animal stress, which, together with

our staff’s experience, guarantees

quality experimental results.

The AH team is duly accredited in

accordance with the current

legislation and has vast experience

in most of the species detailed in

Annex II of the order

ECC/566/2015.

Thanks to continuous training and

teamwork, our AH can perform a

great amount of techniques and

experimental procedures with the

reliability and efficiency expected

by our customers.

Species

We have wide experience working with all the species

contemplated in the current legislation as well as target

species of veterinary products.

• rat • mouse • guinea pig

• rabbit • NHP • dog

• cat • minipig • hamster

Specific techniques

We have broad experience performing an array of

specific experimental procedures.

• Clinical and behavioral observations

• Modified Irwin test: rodent

• Functional Observation Battery (FOB): rodent,

NHP, dog, cat

• Mating: rodent, rabbit

• Postnatal evaluation: rat

• ECGs with snapshots and jackets: NHP, dog, cat,

minipig

• Blood pressure: NHP, dog

• Intraocular pressure: rabbit, dog Administration routes

We offer a variety of administration routes and the

experience of our technicians guarantees correct praxis.

• oral (gavage, diet,

capsules and tablets)

• intravenous (bolus,

infusion)

• subcutaneous • intramuscular

• intraperitoneal • dermal/intradermal

• ocular • intravaginal/intrarectal

• nasogastric (in NHPs) • intranasal (in rodents

and cats)

12

Page 13: ANAPATH 2021 Company Introduction

AH1 AreaRodents and Rabbits

AH1 Rodents and rabbits

Rodents (14 rooms)

• rats: 80-450 animals/room

• mice: 185-400 animals/room

• guinea pigs: 70-200 animals/room

Rabbits (10 rooms)

• 5 rooms of 27 animals each

• 5 rooms of 39 animals each

AH2 NHP

NHP (7 rooms)

• Cages/room: 3-13

• Animals/cage: 3-7

AH3 Dogs, cats and minipigs

Dogs (14 rooms)

• 7 rooms of 32 animals each

• 7 rooms of 16 animals each

• 1 telemetry room of 6 animals

Cats (7 rooms)

• Freely housed animals/room: 32

• Animals/cage: 3-4

Minipigs (7 rooms)

• Animals/room: 16

Animals are housed in different areas,

depending on the species:

• AH1: rodents and rabbits

• AH2: NHP

• AH3: dogs, cats, minipigs

13

Capabilities

Page 14: ANAPATH 2021 Company Introduction

AH2 AreaNHP

AH3 AreaCats, Dogs and

Minipigs

14

Page 15: ANAPATH 2021 Company Introduction

Necropsy & Histology

This service to General Toxicology

is provided jointly by the local

Pathology Department, headed by

an ECVP Board Certified

Pathologist and the integrated

capacity of AnaPath Services.

AnaPath Services is a specialized

CRO, renown and unique in its

expertise of and dedication to

toxicologic histopathology.

The team consists of over 25

skilled technicians, cross-trained

and harmonized in both necropsy

techniques and histological

processing.

Six qualified and highly experienced

pathologists, headed by Dr. Klaus Weber,

DJSTP,providesufficientcapacity toadjust

totighttimelines ifnecessary.

Necropsy service - rodents and

non-rodentsRoutine studies, standard and special trimming: RITA,

Young, Sagartz and other schemas as required

Studies with special sampling requirements:

• Organ sampling, e.g. for qPCR, IHC on frozen or

formalin-fixed tissue, ophthalmic studies

15

Histotechnique - rodents and

non-rodents

• Capacity of 45’000 H&E stained tissues per month

• Other routinely used stains: PAS, Perls’ Prussian

Blue, Oil Red O, Alcian Blue, May-Grünwald Giemsa,

Sirius-Red, Fluoro-Jade, Azan, Methylgreen-

Pyronin, etc.

• Neuropathology processing

• Plastic/resin/hard material embedding

• 100% QC check of histological slides

• Hight throughput slide scanning

Page 16: ANAPATH 2021 Company Introduction

Pathology Our pathologists are renown

scientists with up to 35 years of

experience. They are trained in all

laboratory animals, rodents and

non-rodents, and other species

including but not limited to fish,

frog, snails, worms and birds. Their

publication record is impressive

and rare for a CRO. It reflects the

hundreds of thousands of tissues

evaluated combined with scientific

excellence and outstanding

attention to detail.

Certification of our pathologist Dr.

Klaus Weber by the Japanese

Society of Toxicologic Pathology is

another indication of our global

scientific recognition. The level of

our expert knowledge in

oncogenicity studies,

neuropathology, inhalation

pathology, sperm and ovary

staging, bone marrow evaluation

or cardiovascular pathology is rare

to find.

Histopathological examination

• Toxicologic pathology

• Fetal pathology

• Medical device pathology

• Experimental Pathology

• Molecular pathology

• Peer reviews

• Tumor analysis

• 3D culture evaluation

• Evaluation of electron micrographs, EDX analysis,

hyperspectral microscopy, laser scanning and digital

microscopy

• Training in machine learning programs for automated

histomorphometric analysis

16

Ecotoxicology and endocrine disruptor

Fast processing and evaluation of ecotoxicology studies in

frog, snail, earthworm and fish owing to our huge capacity.

NASH, fibrosis, lung histopathology

AnaPath provides tailored examination based on our

experience.

As an example, for NASH we can deliver the usual Nash

score read out or the extended AnaPath NASH scoring

system.

Semiquantitative analysis of NASH score can be

supported by quantitative image analysis tailored for the

respective needs, measuring cellular structures like

vacuole parameter (steatosis), collagen (fibrosis) and

inflammatory/immune cells to quantify lobular

inflammation.

Page 17: ANAPATH 2021 Company Introduction

Molecular Pathology

The Molecular Pathology Department

of AnaPath has more than 15 years of

experience in biomarker analysis for

pre-clinical development.

Our experienced pathologists and

cell/molecular biologists will

support you to answer the critical

questions. We can select from a

portfolio of established biomarkers

and technologies to choose the

best approach for your preclinical

study. The list of available

biomarkers is continuously

expanding.

Furthermore, we offer FISH and

qPCR analysis using CE/IVD-

certified instruments. This

technique allows us to provide

additional molecular analyses, such

as gene expression, identification

of mutations, SNP genotyping and

detection of infectious diseases.

Immunohistochemistry

The fully automated Leica BOND-III system operated by

experienced technicians secures reliable and constant

staining results on fresh frozen or FFPE samples

Efficient IHC staining protocol development based on

experience with numerous established biomarkers

Conduction of IHC studies under GLP or non-GLP

including qualitative/semiquantitative evaluation by an

experienced pathologist or quantitative image analysis

by computer-assisted tools

Tissue cross-reactivity studies

GLP compliant TCR analysis of therapeutic monoclonal antibodies on human tissue panels following FDA and EMA requirements

All tissue samples evaluated by a pathologist prior to study start to guarantee human tissue panels of the highest quality

Furthermore, TCR might help to understand similarities and differences of drug target localization and expression between species

17

Quantitative real time PCR (qPCR)

Gene expression analysis to have a better understanding of drug’s mechanism of action. Can be combined with Laser Capture Microdissection to analyze specific regions within a tissue section

Mutation analysis to predict risk of disease, identify targeted treatments and anticipate drug response

Single nucleotide polymorphism (SNP) analysis (genotyping) to provide relevant information on susceptibility to diseases

Detection and quantification of infectious pathogens within an investigated sample

Page 18: ANAPATH 2021 Company Introduction

Special Technologies

AnaPath a myriad of technologies for

special evaluation and for solving

unusual challenges in pathology. We

have established a large variety of

measurements for quantitative data to

provedifferentendpoints.

Experienced scientists and

pathologists can also help making a

series of customized

measurements, designed to

demonstrate special endpoints

specific to your device.

Imaging and microscopic technologies

• Scanning electron microscopy (SEM)

• Energy dispersive x-ray analysis (EDX)

• 3D confocal laser scanning microscopy

• Digital microscopy

• Hyperspectral microscopy

• Laser capture microscopy

• Artificial intelligence-driven image analysis

• Slide scanning up to 100X magnification

18

Page 19: ANAPATH 2021 Company Introduction

In Anapath, we have worked with all types of molecules, including:

19

MoleculeExpertise

Biomolecules

• Vaccines (mRNA, AADvac, others)

• ADCs

• Alarelin

• DNA aptamer

• LongLasting Insulines

• Long Lasting Glucagon

• Long Lasting EPO

• Exendin

• Monoclonal antibodies , including biosimilars(Denosumab, Tocilizumab, Avastin, Etanercept)

• hGF

• Interferons

• Clexane (anti Xa /anti IIa)• Ciclosporin

• Argyrin F

• Pidotimod

• Alarelin

• Salinomycin

• Octreotide

• Vancomycin

• Colistin

NCE

• Bilastine

• LMWH

• Cannabinoids

• Opiates

• Risperidone

• Dexamethasone

• MTX

• Antibiotics (Rifampicin, Penicillin, others)

• Metamizole

• Praziquantel

• Fenbendazole

• Oxfendazole

• Acadesine

• ZMP

• Risperidone

• Lipochroman-6

• ZTP

• CBPI

• Olanzapine

• Tetrazicar

• Diclazuril

• Cypermethrin

• Domperidone

• Flubendazole

• Ibudilast

• Sulfadiazine

• Trimethoprim

• Topiramate

• Dexamethasone

• Sulfadimidine

• Doxycycline

• 5-methylthioadenosine (MTA)

• Paclitaxel

• 2-Hydroxyoleic Acid

• Genistein

• Doxorubicin

• 2'Fucosyllactose

• Brinzolamide

• Chloranfenicol

• Tiamulin

• Penicillin G

• Phoxim

• Amoxicillin

• Spectinomycin

• lincomycin

• Dihydrospectinomycin

• Oxytetracycline

• Closantel

• mebendazol

• Benzylpenicillin

• Ketoprofen

• Tilmicosin

• Albendazol

• Meloxicam

• Ceftiofur

• Tylosin

• Chlorfenvinphos

• Butaphosphan

• Darifenacin

• Clenbuterol

• Desoxypeganin

• Difenoconazole

• Dopamine

• Fenbutatin

• Acethylcholine

• Choline

• Dopac

• Bumetanide

Page 20: ANAPATH 2021 Company Introduction

20

Back to the origin,and fly high

Page 21: ANAPATH 2021 Company Introduction

ContactAnaPath Research, Spainanapathresearch.com

Centro Industrial Santigac/Argenters, 608130 Santa Perpètua de MogodaBarcelona / Spain

---

Ctra. Castellar del Vallès a SentmenatC-1415a, km 2908211 Castellar del VallèsBarcelona / Spain

AnaPath Services, Switzerlandanapath.ch

Hammerstrasse 494410 LiestalSwitzerland

21

AnaPath Services, Koreaanapath.ch

Guk-Jin [email protected]

Shin [email protected]

Page 22: ANAPATH 2021 Company Introduction

22